April Sabo

April Sabo is a seasoned sales professional with a diverse background in the pharmaceutical and healthcare industries. Currently serving as a Senior Executive Sales Specialist at Corium, Inc., April successfully launched the first d-MPH prodrug with an IR component in Arizona. Previous experience includes roles at Xeris Pharmaceuticals, where April contributed to the launch of GVOKE PFS and the Gvoke HypoPen, and at Tris Pharma, focusing on Dyanavel XR for ADHD. Additionally, April's experience extends into real estate, diabetes care, and sales within various organizations, showcasing strong negotiation and client relationship skills developed over a career spanning over two decades. Education includes a Bachelor of Arts in Criminal Justice from Kent State University.